Nevertheless, differences in the TIM-3 expression were expected, as these findings were obtained from only newly diagnosed ALL pediatric patients aged 2–10 years, unlike the current study in which PB samples were collected from patients aged 12.1 ± 14.9. The gene discussed is HAVCR2; the disease is acute lymphoblastic leukemia.